Every advance in prostate cancer care begins years before a patient ever receives a diagnosis, a new treatment becomes available, or survival rates improve. It begins with researchers asking scientific questions that have yet to be answered, and with the resources to pursue discoveries capable of fundamentally changing how prostate cancer is detected, treated, and understood.

For more than 30 years, the Home Run Challenge has helped make that work possible. Every donation enables the Prostate Cancer Foundation to identify, fund, and accelerate some of the world’s most promising scientists through programs like our Young Investigator, TACTICAL, and Challenge Awards. These investments support innovative research at its earliest stages, where today’s scientific questions become tomorrow’s life-saving breakthroughs.

Today, hear directly from one of the researchers helping advance that progress.



Dr. Jason Lewis, Emily Tow Chair and Deputy Director of the Sloan Kettering Institute, is among the world-renowned researchers advancing the future of prostate cancer care through PCF-funded research. As a recipient of a PCF TACTICAL Award and co-investigator on a PCF Challenge Award, his work reflects the scientific innovation made possible through philanthropy. Hear his perspective on one simple question:

“What excites you most about what you’re seeing in prostate cancer research today?”

Every gift to the Home Run Challenge helps support researchers like Dr. Lewis, whose discoveries are advancing new approaches to prostate cancer detection and treatment while bringing hope to patients and families around the world.